Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Exon Skipping and Inclusion Therapies -

Exon Skipping and Inclusion Therapies

Methods and Protocols
Buch | Softcover
569 Seiten
2019 | Softcover reprint of the original 1st ed. 2018
Humana Press Inc. (Verlag)
978-1-4939-9354-3 (ISBN)
CHF 247,15 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
This book presents a comprehensive collection of detailed state-of-the-art exon skipping and splices modulation protocols. Chapters detail 14 genetic diseases, AON-mediated therapies, and CRISPR/Cas9-mediated gene editing therapies. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.



Authoritative and cutting-edge, Exon Skipping and Inclusion Therapies: Methods and Protocols aims to help researchers initiate the development of next-generation therapies.

Invention and Early History of Exon Skipping and Splice Modulation.- An Overview of Recent Advances and Clinical Applications of Exon Skipping and Splice Modulation for Muscular Dystrophy and Various Genetic Diseases.- Recent Advances and Clinical Applications of Exon Inclusion for Spinal Muscular Atrophy.- Nusinersen in the Treatment of Spinal Muscular Atrophy.- Tips to Design Effective Splice-switching Antisense Oligonucleotides for Exon Skipping and Exon Inclusion.- Antisense Oligonucleotide Targeting of 3’UTR of mRNA for Expression Knockdown.- Quantitative Evaluation of Exon Skipping in Immortalized Muscle Cells In Vitro.- Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-m Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.- In vitro Multi-exon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.- Creation of DMD Muscle Cell Model using CRISPR-Cas9 Genome Editing toTest the Efficacy of Antisense-mediated Exon Skipping.- In vitro Evaluation of Exon Skipping in Disease Specific iPSC-derived Myocytes.- Restoration of Dystrophin Protein Expression by Exon Skipping utilizing CRISPR-Cas9 in Myoblasts Derived from DMD Patient iPS Cells.- Skipping of Duplicated Dystrophin Exons: in vitro Induction and Assessment.- In Vivo Evaluation of Dystrophin Exon Skipping in mdx Mice.- Exon 51 Skipping Quantification by Digital Droplet PCR in del52hDMD/mdx Mice.- Systemic Injection of Peptide-PMOs into Humanized DMD Mice and Detection by RT-PCR and ELISA.- In vivo Evaluation of Single- and Multi-exon Skipping in mdx52 Mice.- A Novel Zebrafish Model for Assessing In Vivo Delivery of Morpholino Oligomers.- Validation and Detection of Exon Skipping Boosters in DMD Patient Cell Models and mdx Mouse.- Use of Glucose/Fructose to Enhance the Exon Skipping Efficacy.- Systemic Intravenous Administration of Antisense Therapeutics forCombinatorial Dystrophin and Myostatin Exon Splice Modulation.- The Assembly of Fluorescently Labeled Peptide-oligonucleotide Conjugates via Orthogonal Ligation Strategies.- In vivo Evaluation of Multiple Exon Skipping with Peptide-PMOs in Cardiac and Skeletal Muscles in Dystrophic Dogs.- Use of Tricyclo-DNA Antisense Oligonucleotides for Exon Skipping.- Optimization of 2ʹ,4ʹ-BNA/LNA–based Oligonucleotides For Splicing Modulation in vitro.- Pre-Mrna Splicing Modulation by Antisense Oligonucleotides.- In vitro Evaluation of Antisense-mediated Exon Inclusion for Spinal Muscular Atrophy.- Systemic Injection of Antisense oligos into SMA Mice and Evaluation.- Exon Skipping using Antisense Oligonucleotides for Laminin-alpha2-deficient Muscular Dystrophy.- Exon Skipping by Ultrasound-enhanced Delivery of Morpholino with Bubble Liposomes for Myotonic Dystrophy Model Mice.- Dysferlin Exon 32 Skipping in Patient Cel­ls.- Morpholino-mediated Exon Skipping Targeting Human ACVR1/ALK2 for Fibrodysplasia Ossificans Progressiva.- Exon Skipping of FcεRIβ for Allergic Diseases.- Antisense Oligonucleotide Design and Evaluation of Splice-modulating Properties Using Cell-based Assays.- Antisense-mediated Splice Modulation to Reframe Transcripts.- Morpholino-mediated Exon Inclusion for SMA. 

Erscheinungsdatum
Reihe/Serie Methods in Molecular Biology ; 1828
Zusatzinfo 77 Illustrations, color; 26 Illustrations, black and white; XV, 569 p. 103 illus., 77 illus. in color.
Verlagsort Totowa, NJ
Sprache englisch
Maße 178 x 254 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete
Studium 2. Studienabschnitt (Klinik) Humangenetik
Schlagworte iPS-derived muscle • mRNA splicing • myotonic dystrophy • Tricyclo-DNA • Zebrafish
ISBN-10 1-4939-9354-2 / 1493993542
ISBN-13 978-1-4939-9354-3 / 9781493993543
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Eine sehr persönliche Geschichte | Der New York Times-Bestseller

von Siddhartha Mukherjee

Buch | Softcover (2023)
Ullstein Taschenbuch Verlag
CHF 30,75
Die revolutionäre Medizin von morgen (Lifespan)

von David A. Sinclair; Matthew D. LaPlante

Buch | Softcover (2020)
DuMont Buchverlag
CHF 22,40